Ranbaxy Recalls Antibiotic in U.S.

9:59 AM MDT | May 8, 2009

Ranbaxy Pharmaceuticals, a Ranbaxy Laboratories (Gurgaon, India) subsidiary, says it has voluntarily recalled its antibiotic nitrofurantoin capsules from the U.S. market, as certain lots of the product did not conform with approved laboratory specifications. The recall is being coordinated with the U.S. FDA and will be on a retail level, Ranbaxy says. The company says it is looking into the cause of the non-conformity, and that the recalled products are unlikely to produce any serious adverse health effects. However, the company says there is a “remote...